Author: digi

Engagement Tactics to Turn Investigators Into Study Champions

Posted on By digi

Engagement Tactics to Turn Investigators Into Study Champions Engagement Tactics to Turn Investigators Into Study Champions In the ever-evolving landscape of clinical research, the role of investigators is paramount. Not only do they conduct the trials, but they also influence patient recruitment, retention, and overall study success. Proper engagement strategies can turn an ordinary investigator…

Read More “Engagement Tactics to Turn Investigators Into Study Champions” »

Investigator Meeting & Site Initiation Visit

Cross-Functional RACI Models for Implementing ICH E6(R3) Across the Portfolio

Posted on By digi

Cross-Functional RACI Models for Implementing ICH E6(R3) Across the Portfolio Cross-Functional RACI Models for Implementing ICH E6(R3) Across the Portfolio The successful implementation of ICH E6(R3) guidelines requires a comprehensive understanding of roles, responsibilities, and compliance expectations across different functional areas within pharmaceutical and clinical research organizations. In this article, we will provide a step-by-step…

Read More “Cross-Functional RACI Models for Implementing ICH E6(R3) Across the Portfolio” »

ICH E6(R3) Principles & Proportionality

Risk Assessment and Risk Control Requirements Under Updated GCP

Posted on By digi

Risk Assessment and Risk Control Requirements Under Updated GCP Understanding Risk Assessment and Risk Control Requirements Under Updated GCP Introduction to ICH E6(R3) and Its Impact on Clinical Trials The International Council for Harmonisation (ICH) has been instrumental in setting the standards for Good Clinical Practice (GCP) globally. The release of ICH E6(R3) introduces significant…

Read More “Risk Assessment and Risk Control Requirements Under Updated GCP” »

ICH E6(R3) Principles & Proportionality

Translating Corporate Quality Policies Into Study-Level QMS Controls

Posted on By digi

Translating Corporate Quality Policies Into Study-Level QMS Controls The successful execution of clinical trials relies on the rigorous application of a Quality Management System (QMS) that adheres to corporate quality policies while addressing study-specific requirements. This comprehensive guide outlines a step-by-step tutorial for clinical operations, regulatory affairs, and medical affairs professionals in the US, UK,…

Read More “Translating Corporate Quality Policies Into Study-Level QMS Controls” »

Quality Management System (QMS) Design

Standardized SIV Checklists for Drug, Device and Combination Product Trials

Posted on By digi

Standardized SIV Checklists for Drug, Device and Combination Product Trials Standardized SIV Checklists for Drug, Device and Combination Product Trials The initiation of clinical trials is a critical activity that requires meticulous planning and execution. Site Initiation Visits (SIVs) represent a vital stage in the clinical trial lifecycle, ensuring that clinical sites are prepared to…

Read More “Standardized SIV Checklists for Drug, Device and Combination Product Trials” »

Investigator Meeting & Site Initiation Visit

Proportionate GCP Oversight for Low-Intervention and Pragmatic Clinical Trials

Posted on By digi

Proportionate GCP Oversight for Low-Intervention and Pragmatic Clinical Trials Clinical trials serve as the cornerstone of medical research, enabling the testing of new treatments and medical interventions to improve patient outcomes. However, the extent of oversight and regulation applied to clinical trials can vary significantly based on the nature of the trial itself. This article…

Read More “Proportionate GCP Oversight for Low-Intervention and Pragmatic Clinical Trials” »

ICH E6(R3) Principles & Proportionality

Embedding ICH E6(R3) Into SOPs, Templates and Study Governance

Posted on By digi

Embedding ICH E6(R3) Into SOPs, Templates and Study Governance The International Council for Harmonisation (ICH) E6(R3) provides comprehensive guidance intended to strengthen the quality of clinical trials globally. This article outlines a structured approach for clinical operations, regulatory affairs, and medical affairs professionals to effectively embed ICH E6(R3) principles into Standard Operating Procedures (SOPs), templates,…

Read More “Embedding ICH E6(R3) Into SOPs, Templates and Study Governance” »

ICH E6(R3) Principles & Proportionality

Risk-Based Clinical QMS Design Aligned With ICH E6(R3) and ICH E8(R1)

Posted on By digi

Risk-Based Clinical QMS Design Aligned With ICH E6(R3) and ICH E8(R1) In the evolving landscape of clinical trials, the importance of a robust Quality Management System (QMS) cannot be overstated. This article provides a step-by-step tutorial guide focused on designing a risk-based clinical QMS that is compliant with ICH E6(R3) and ICH E8(R1). This guidance…

Read More “Risk-Based Clinical QMS Design Aligned With ICH E6(R3) and ICH E8(R1)” »

Quality Management System (QMS) Design

From E6(R2) to E6(R3): Translating New GCP Principles Into Site and Sponsor Practice

Posted on By digi

From E6(R2) to E6(R3): Translating New GCP Principles Into Site and Sponsor Practice From E6(R2) to E6(R3): Translating New GCP Principles Into Site and Sponsor Practice The ongoing evolution of Good Clinical Practice (GCP) directly influences the operation and management of clinical trials in regulated environments such as the US, UK, and EU. With the…

Read More “From E6(R2) to E6(R3): Translating New GCP Principles Into Site and Sponsor Practice” »

ICH E6(R3) Principles & Proportionality

Designing Quality by Design Frameworks That Align With ICH E6(R3)

Posted on By digi

Designing Quality by Design Frameworks That Align With ICH E6(R3) The International Conference on Harmonisation (ICH) E6(R3) is a paradigm shift in clinical trial design and conduct that emphasizes the principles of Quality by Design (QbD). This framework aims to enhance the quality of clinical trials, particularly focusing on the integration of proportionality principles. This…

Read More “Designing Quality by Design Frameworks That Align With ICH E6(R3)” »

ICH E6(R3) Principles & Proportionality